Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EMTRICITABINE, with a corresponding US DMF Number 23773.
Remarkably, this DMF maintains an Active status since its submission on April 28, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 09, 2013, and payment made on April 17, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II